Global Study Reveals Only Five Percent of Health Organizations Excel at Digital Innovation

NEW YORK, April 21, 2016 /PRNewswire/ -- Enspektos, LLC, a leading innovation consultancy, announced today the results from Wave 1 of its State of Digital Health Innovation Study.  This research initiative is designed to help the global health ecosystem understand how organizations are progressing in their digital innovation efforts.

This research reveals that:

• Only 5% of health organizations are operating at the highest level of digital health innovation proficiency and expertise
• The majority of organizations globally are in the digital health pilot testing and experimentation phase
• Progress is slow even in relatively mature technology areas such as social media and mobile
• Organizations do not yet have sufficient technical expertise or budgetary resources to efficiently scale their innovation efforts

"This industry-first study clearly illustrates the challenges health organizations face in executing digital innovation," said Fard Johnmar, founder and president of Enspektos. "But I'm encouraged. This research provides much-needed actionable insights that organizations and their partners can use to accelerate the implementation of high-impact digital innovation activities globally."

"As we see from this study, digital health is accelerating due to many driving forces, including technology, economic dynamics, policy and the consumerization of healthcare.  This research is more evidence that health organizations are moving from talking about to actually doing digital health," said Chris Edwards, Chief Marketing Officer for Validic, which sponsored this research.

Click here to access a free report outlining the study results and strategic digital health innovation recommendations for organizations and their partners.

About This Study

Enspektos fielded Wave 1 of the State of Digital Health Innovation Study between December 2015 and February 2016. More than 360 individuals working at health organizations (hospitals, pharmaceutical firms, payers) or their partners (technology firms, startups, etc.) from around the world were recruited via email and other channels. 150 were qualified to participate in the study due to their in-depth knowledge of organizations' digital health innovation activities (budgets, leadership support, etc.). This study was produced with the support of Validic.

About Enspektos and Validic

Enspektos (www.enspektos.com) is a globally respected innovation consultancy. Over the last 10 years, we have helped entrepreneurs, executives, medical professionals and others understand, innovate and excel in digital health. This research is part of Enspektos' Digital Health Maven Project, which aims to develop a global cadre of individuals with the skills, knowledge and confidence to radically transform health.

As the industry's leading digital health platform, Validic reaches more than 223 million lives in 47 countries. Validic was named to Gartner's "Cool Vendors" list and received Frost & Sullivan's "Best Practices and Best Value in Healthcare Information Interoperability" and "Top 10 Healthcare Innovating Disruptor" awards. To learn more about Validic, follow Validic on Twitter or visit www.validic.com.

Media Contact:     
Fard Johnmar
646.723.2341, ext. 3

SOURCE Enspektos, LLC

Related Links

http://www.enspektos.com